Skip to content

Assess effect of angiographic embolisation of the tumor vessels (with chemotherapy drug ) and surgery on tumor cells circulating in blood in hepatocellular cancer patients

EFFECT OF PRE-OPERATIVE TRANSARTERIAL CHEMO-EMBOLISATION ON CIRCULATING TUMOR CELLS AND RECURRENCE IN HEPATOCELLUAR CARCINOMA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/06/007049
Enrollment
10
Registered
2016-06-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Hepatocellular carcinoma Health Condition 2: C220- Liver cell carcinoma

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients of HCC deemed resectable based on clinico-radiological criteria with or without histological proof and child-Pugh status after Joint clinic discussion will be counseled for getting enrolled in the study Following patients with HCC are considered for resection and will be encouraged to participate in the study Non metastatic HCC in a non cirrhotic or a Childs A cirrhotic patient if adequate FLR future liver remnant can be ensured post resection and if R0 resection can be achieved Solitary HCC irrespective of the size of the tumor Low volume disease few lesions up to 4 multicentric disease, localized in one lobe if can be completely resected

Exclusion criteria

Exclusion criteria: Patients of HCC planned in Joint clinic for treatment options other than Resection Patients enrolled but intra operatively found to be inoperable Patients refusing to participate in the study

Design outcomes

Primary

MeasureTime frame
Overall SurvivalTimepoint: 12 month

Secondary

MeasureTime frame
CTC level measurement at 6month post surgery Disease free SurvivalTimepoint: 12 month;CTC level measurement at 6month post surgery Disease free SurvivalTimepoint: 12 month

Countries

India

Contacts

Public ContactDr Vikram Chaudhari

Tata Memorial Hospital

drmaheshgoel@gmail.com9820504492

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026